Generated: April 29, 2017
|Title:||Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders|
|Abstract:||One or more formulations for treating psoriasis and other skin disorders characterized by redness, itching, flaking, scaling, and plaque-type growth. The formulation includes a carrier component, one or more active ingredient components, and a surfactant component. The carrier preferably includes an alcohol in substantially equal volume with isopropyl myristate. The active ingredient component preferably includes a superpotent or high-potency corticosteroid such as clobetasol propionate, an anti-flaking ingredient such as zinc pyrithione, or a combination of the two. It may also include an anti-fungal compound. The surfactant component preferably includes an alkyl sulfate such as sodium lauryl sulfate. The formulations made by applied topically either in spray form or as a direct-contact liquid.|
|Inventor(s):||Seidel; William E. (Scarborough, ME)|
|Assignee:||Dermalogix Partners, Inc. (Scarborough, ME)|
Patent Claim Types:|
see list of patent claims
|Use; Formulation; Compound; Composition;|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
Galderma Labs Lp
|SPRAY;TOPICAL||021835-001||Oct 27, 2005||AT||RX||Yes||Yes||5,972,920||► Subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.